The problems of delivering neuroactive molecules to the CNS

CIBA Foundation Symposia

Volumn , Issue 196, 1996, Pages 211-239

  Tan, Sanda A ^a   Aebischer, Patrick ^a  

^a University of Lausanne Medical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG ADMINISTRATION ROUTE; HUMAN; METABOLISM; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG ADMINISTRATION ROUTES; HUMANS;

EID: 0030344755     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (113)

1. Aebischer P, Kato AC 1995 Treatment of amyotrophic lateral sclerosis using a gene therapy approach. Eur Neurol 35:65-68
2. Aebischer P, Winn SR, Galletti PM 1988 Transplantation of neural tissue in polymer capsules. Brain Res 448:364-368
3. Aebischer P, Tresco PA, Winn SR, Greene LA, Jaeger CB 1991a Long-term cross-species brain transplantation of a polymer encapsulated dopamine secreting cell line. Exp Neurol 111:269-275
4. Aebischer P, Tresco PA, Sagen J, Winn SR 1991b Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res 560:43-49
5. Aebischer P, Wahlberg L, Tresco PA, Winn SR 1991c Macroencapsulation of dopamine secreting cells by co-extrusion with an organic polymer solution. Biomaterials 12:50-56
6. Aebischer P, Winn SR, Tresco PA, Jaeger CB, Greene LA 1991d Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique. J Biomech Eng 113:178-183
7. Aebischer P, Goddard M, Signore A, Timpson R 1994a Functional recovery in Hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp Neurol 126:151-158
8. Aebischer P, Buchser E, Joseph JM et al 1994b Transplantation in humans of encapsulated xenogeneic cells without immunosuppression: a preliminary report. Transplantation 58:1275-1277
9. Alderson RF, Alterman AL, Barde YA, Lindsay RM 1990 Brain-derived neurotrophic factor increases survival and differentiation functions of rat septal cholinergic neurons in culture. Neuron 5:297-306
10. Alter CA, Boylan CB, Jackson C et al 1992 Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turn-over in vivo. Proc Natl Acad Sci USA 89:11347-11351
11. Andén NE, Carlsson A, Dahlström A, Fuxe K, Hillarp NA, Larsson K 1966 Demonstration and mapping out of nigrostriatal dopamine neurons. Life Sci 3:523-530
12. Backlund EO, Granberg PO, Hamberger B et al 1985 Transplantation of adrenal medullary tissue to striatum in Parkinsonism: 1st clinical trials. J Neurosurg 62:169-173
13. Barinaga M 1994 Neurotrophic factors enter the clinic. Science 264:771-774
14. Becker J, Robinson TE, Barton P, Sintov A, Siden R, Levy RJ 1990 Sustained behavioral recovery from unilateral nigrostriatal damage produced by the controlled release of dopamine from a silicone polymer pellet placed into the denervated striatum. Brain Res 508:60-64
15. Bellamkonda R, Ranieri JP, Aebischer P 1995a Laminin oligopeptide derivatized agarose gels allow three-dimensional neunte extension in vitro. J Neurosci Res 41:501-509
16. Bellamkonda R, Ranieri JP, Bouche N, Aebischer P 1995b Hydrogel-based three-dimensional matrix for neural cells. J Biomed Mater Res 29:663-671
17. Bird ED, Iversen LL 1974 Huntington's chorea: postmortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97:457-472
18. Birkmayer W, Hornykiewicz O 1962 Der L-dioxyphenylalain (L-dopa)-effekt beim Parkinson-syndrom des menschen. Zur pathogenese und behandlung der Parkinsonakinese. Arch Psychiat Nervenkr 203:560-574
19. Björklund A 1991 Neural transplantation: an experimental tool with clinical possibilities. Trends Neurosci 14:319-322
20. Brem H, Mahaley MS Jr, Vick NA et al 1991 Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441-446
21. Brooks BR, Sanjak M, Mitsumoto H et al 1993 Recombinant human ciliary neurotrophic factor (rhCNTF) in amyotrophic lateral sclerosis (ALS) patients: dose selection strategy in Phase I-II safety, tolerability and pharmacokinetic studies. Can J Neurol Sci (suppl) 4:83S
22. Brundin P, Nilsson OG, Strecker RE, Lindvall O, Astedt B, Björklund A 1986 Behavioral effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 65:235-240
23. Chen LS, Ray J, Fisher LJ et al 1991 Cellular replacement therapy for neurologic disorders: potential of genetically engineered cells. J Cell Biochem 45:252-257
24. Crooks CA, Douglas JA, Broughton RL, Sefton MV 1990 Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. J Biomed Mater Res 24:1241-1262
25. Dahlström A, Fuxe K 1964 Evidence for the existence of monoamine containing neurons in the central nervous system. Acta Physiol Scand 232:1-55
26. Date I, Felton SY, Felton DL 1990 Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice. Brain Res 537:33-39
27. Dawson RM, Broughton RL, Stevenson WTK, Sefton MV 1987 Microencapsulation of CHO cells in hydroxyethyl methacrylate-methyl methacrylate copolymer. Biomaterials 8:360-368
28. De Yebenes JG, Fahn S, Jackson-Lewis V, Jorge P, Mena MA, Reiriz J 1988 Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease. J Neural Transplant 27:141-160
29. Dichter MA, Ayala GF 1987 Cellular mechanism and epilepsy. Science 237:157-164
30. Dittrich F, Thoenen H, Sendtner M 1994 Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol 335:151-163
31. Dupuy B, Gin H, Baquey C, Ducassou D 1988 In situ polymerization of a microencapsulating medium around living cells. J Biomed Mater Res 22:1061-1070
32. During MJ, Naegele JR, O'Malley KL, Geller AI 1994 Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403
33. Emerich DF, Grydel BR, Glanagen TR, Palmatier M, Winn SR, Christenson L 1993 Transplantation of polymer encapsulated PC12 cells: use of chitosan as an immobilization matrix. Cell Transplant 2:241-249
34. Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH 1994a Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 349:148-164
35. Emerich DF, Hammang JP, Baetge EE, Winn SR 1994b Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp Neurol 130:141-150
36. Enna SJ 1976 Huntington's chorea: changes in neurotransmitter receptor in the brain. N Engl J Med 294:1305-1309
37. Freed WJ, Morihisa JM, Spoor E et al 1981 Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature 292:351-352
38. Freed WJ, Cannon-Spoor HE, Krauthamer E 1986 Intrastriatal adrenal medulla grafts in rats. Long-term survival and behavioral effects. J Neurosurg 65:664-670
39. Freed WJ, Willingham G, Heim R 1992a Effects of adrenal medulla and sciatic nerve cograft in rats with unilateral substantia nigra lesions. J Neural Transplant & Plast 3:159-167
40. Freed CR, Breeze RE, Rosenburg NL et al 1992b Survival of implanted fetal dopamine cells and neurologic improvement in 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555
41. Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk RM 1991 Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci USA 88:4771-4775
42. Friden PM, Walus LR, Watson P et al 1993 Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259:373-377
43. Goosen MFA, O'Shea GM, Gharapetian HM, Chou S, Sun AM 1985 Optimization of microencapsulation parameters: semi-permeable rnicrocapsules as a bioartificial pancreas. Biotechnol Bioeng 27:146-150
44. Hama AT, Sagen J 1993 Reduced pain-related behavior by adrenal medullary transplant in rats with experimental painful peripheral neuropathy. Pain 52:223-231
45. Hargraves R, Freed WJ 1987 Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigra. Life Sci 40:959-966
46. Hefti F, Dravid A, Hartikka J 1984 Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res 293:305-311
47. Hefti F, Hartikka J, Schlumpf M 1985 Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res 348:283-288
48. Henderson CE, Phillips HS, Pollock RA et al 1994 GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062-1064
49. Hoffman D, Wahlberg L, Aebischer P 1990 NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp Neurol 110:39-44
50. Hoffman D, Breakefield XO, Short MP, Aebischer P 1993 Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp Neurol 122:100-106
51. Horellou P, Guibert B, Leviel V, Mallet J 1989 Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc Natl Acad Sci USA 86:7233-7237
52. Horellou P, Brundin P, Kalen P, Mallet J, Björklund A 1990 In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5:393-402
53. Horellou P, Lundberg C, Le-Bourdelles B et al 1991 Behavioral effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's disease. J Physiol 85:158-170
54. Hornykiewicz O 1966 Dopamine (3-hydroxythyamine) and brain function. Pharmacol Rev 18:925-964
55. Hughes RA, Sendtner M, Thoenen H 1993 Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 36:663-671
56. Ip NY, Yancopoulos GD 1993 Receptors and signaling pathways of ciliary neurotrophic factor and the neurotrophins. Neuroscience 5:249-257
57. Jaeger CB 1985 Immunocytochemical study of PC12 cells grafted to the brain of immature rats. Exp Brain Res 59:615-624
58. Jiao S, Gurevich V, Wolff JA 1993 Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362:414-415
59. Joseph JM, Goddard MB, Mills J et al 1994 Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Cell Transplant 3:355-364
60. Knusel B, Winslow JW, Rosenthal A et al 1991 Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc Natl Acad Sci USA 88:961-965
61. Kokaia M, Aebischer P, Elmér E et al 1994 Seizure suppression in kindling epilepsy by intracerebral implants of GABA-releasing but not by noradrenaline-releasing polymer matrices. Exp Brain Res 100:385-394
62. Kordower JH, Winn SR, Liu YT et al 1994a The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 91:10898-10992
63. Kordower JH, Charles V, Bayer R et al 1994b Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease. Proc Natl Acad Sci USA 91:9077-9080
64. Langer R, Folkman J 1976 Polymers for sustained release of proteins and other macromolecules. Nature 263:797-800
65. Lim F, Sun AM 1980 Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-910
66. Lin L-FH, Doherty DH, Lile JD, Bektesh S, Collins F 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132
67. Lindner MD, Winn SR, Baetge EE et al 1995 Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and Parkinsonian symptoms. Exp Neurol 132:62-76
68. Lindvall O, Backlund EO, Farde L et al 1987 Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol 22:457-468
69. Lindvall O, Brundin P, Widner H et al 1990 Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577
70. McKnight CA, Ku A, Goosen MFA, Sun D, Penney C 1988 Synthesis of chitosan-alginate microcapsule membranes. J Bioact Compat Polym 3:334-339
71. McRae-Degueurce A, Hjorth S, Dillon DL, Mason DW, Tice TR 1988 Implantable microencapsulated dopamine (DA): a new approach for slow-release DA delivery into brain tissue. Neurosci Lett 92:303-309
72. Mellabone CL, Crooks CA, Sefton MV 1989 Microencapsulation of human diploid fibroblasts in cationic polyacrylates. Biomaterials 10:380-386
73. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM 1994 Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265:1107-1110
74. Mulligan RC 1993 The basic science of gene therapy. Science 260:926-932
75. Olson L, Backlund EO, Ebendal T et al 1991 Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One year follow-up of first clinical trial. Arch Neurol 48:373-381
76. Olson L, Nordberg A, von-Holst H et al 1992 Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in an Alzheimer patient case report. J Neural Transm Parkinson's Dis Dementia Sect 4:79-95
77. Pardridge WM, Kumagai AK, Eisenberg JB 1987 Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain-barrier. Biochem Biophys Res Commun 146:307-313
78. Penn RD Intrathecal baclofen for severe spasticity. Ann NY Acad Sci 531:157-166
79. Plautz G, Nabel EG, Nabel GJ 1991 Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 3:709-715
80. Potten CS, Loeffler M 1990 Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110:1001-1020
81. Ray J, Peterson DA, Schinstine M, Gage FH 1993 Proliferation, differentiation, and long-term culture of primary hippocampal neurons. Proc Natl Acad Sci USA 90:3602-3606
82. Reynolds BA, Weiss S 1992 Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710
83. Rosenberg MB, Friedmann T, Robertson RC et al 1988 Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science 242:1575-1578
84. Sabel BA, Bominiak P, Hauser W, During MJ, Freese A 1990 Levodopa delivery from controlled release polymer matrix: delivery of more than 600 days in vitro and 225 days elevated plasma levels after subcutaneous implantations in rats. J Pharmacol Exp Ther 255:914-922
85. Sagen J, Pappas GD, Perlow MJ 1986 Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity. Brain Res 384:189-194
86. Sagen J, Wang H, Pappas GD 1990 Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. Pain 42:69-79
87. Sagen J, Pappas GD, Winnie AP 1993a Alleviation of pain in cancer patients by adrenal medullary transplants in the spinal subarachnoid space. Cell Transplant 2:259-266
88. Sagen J, Wang H, Tresco PA, Aebischer P 1993b Transplants of immunologically-isolated xenogeneic chromaffin cells provide a long-term source of pain reducing neuroactive substances. J Neurosci 13:2415-2423
89. Sagot Y, Tan SA, Baetge E, Schmalbruch H, Kato AC, Aebischer P 1995 Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur J Neurosci 7:1313-1322
90. Sanberg PR, Emerich DF, Aebischer P et al 1993 Substance P containing polymer implants protect against striatal excitotoxicity. Brain Res 628:327-329
91. Scheirer W, Nilsson K, Merten OW, Katinger HWD, Mosbach K 1985 Entrapment of animal cells for the production of biomolecules such as monoclonal antibodies. Dev Biol Stand 55:155-161
92. Seeburger JL, Springer JE 1993 Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis. Exp Neurol 124:64-72
93. Sendtner M, Kreutzberg GW, Thoenen H 1990 Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345:440-441
94. Sendtner M, Schmalbruch H, Stöckli KA, Carroll P, Kreutzberg GW, Thoenen H 1992a Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358:502-504
95. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde Y-A 1992b Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360:757-759
96. Sladek JR, Redmond E, Roth RH 1988 Transplantation of fetal neurons in primates. Clin Res 36:200-204
97. Soon-Shiong P, Heintz R, Merideth N et al 1994 Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950-951
98. Spencer D, Robbins R, Naftolin F et al 1992 Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548
99. Strömberg I, Wetmore CJ, Ebendal T, Ernfors P, Persoon H, Olson L 1990 Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J Neurosci Res 25:405-411
100. Strömberg I, Björklund L, Johansson M et al 1993 Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401-412
101. Tan SA, Déglon N, Zurn AD et al 1995 Rescue of motoneurons from axotomy induced cell death by polymer encapsulated cells genetically engineered to release CNTF, in press
102. Tresco PA, Winn SR, Tan S, Jaeger CB, Greene LA, Aebischer P 1992 Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant 1:255-264
103. Uchida K, Takamatsu K, Kaneda N et al 1989 Synthesis of L-3,4-dihydroxyphenylalanine by tyrosine hydroxylase cDNA-transfected C6 cells: application for intracerebral grafting. J Neurochem 53:728-732
104. Williams LR, Varon S, Peterson GM et al 1986 Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 83:9231-9235
105. Winn SR, Wahlberg L, Tresco PA, Aebischer P 1989a An encapsulated dopamine-releasing polymer alleviates experimental Parkinsonism in rats. Exp Neurol 105:244-250
106. Winn SR, Aebischer P, Galletti PM 1989b Brain reaction to permselective polymer capsules. J Biomed Mater Res 23:31-44
107. Winn SR, Tresco PA, Zielinski B, Greene LA, Jaeger CB, Aebischer P 1991 Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp Neurol 113:322-329
108. Winn SR, Hammang JP, Emerich DF, Lee A, Palmiter RD, Baetge EE 1994 Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 91:2324-2328
109. Wolff JA, Fisher LJ, Xu L et al 1989 Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci USA 86:9011-9014
110. Yan Q, Elliott J, Snider WD 1992 Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 360:753-755
111. Yan Q, Matheson C, Lopez OT 1995 In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373:341-344
112. Zielinksi BA, Aebischer P 1994 Chitosan as a matrix for mammalian cell encapsulation. Biomaterials 15:1049-1056
113. Zurn AD, Baetge EE, Hammang JP, Tan SA, Aebischer P 1995 Glial cell-line derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurons. NeuroReport 6:113-118